Cloning and characterization of the lanosterol 14α-demethylase (ERG11) gene in Cryptococcus neoformans

Biochemical and Biophysical Research Communications

Volumn 324, Issue 2, 2004, Pages 719-728

  Revankar, S G ^a   Fu, J ^a   Rinaldi, M G ^a   Kelly, S L ^b   Kelly, D E ^b   Lamb, D C ^b   Keller, S M ^a   Wickes, B L ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b SWANSEA UNIVERSITY   (United Kingdom)

Author keywords

Candida; Coccidioides; Codehop; Histoplasma; Lanosterol demethylase

Indexed keywords

ANTIFUNGAL AGENT; CYTOCHROME P450; LANOSTEROL; STEROL 14ALPHA DEMETHYLASE; UNSPECIFIC MONOOXYGENASE;

ALGORITHM; ARTICLE; BASIDIOMYCETES; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; ENZYME ANALYSIS; GENE ISOLATION; GENE TARGETING; GENOME; MOLECULAR CLONING; MUTANT; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; SEQUENCE HOMOLOGY;

AJELLOMYCES; BASIDIOMYCOTA; CANDIDA; COCCIDIOIDES; CRYPTOCOCCUS NEOFORMANS; FILOBASIDIELLA NEOFORMANS; SACCHAROMYCES; SACCHAROMYCES CEREVISIAE;

EID: 5144233011     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.09.112     Document Type: Article

References (58)

1. S.P. Franzot, I.F. Salkin, and A. Casadevall Cryptococcus neoformans var. grubii: separate varietal status for Cryptococcus neoformans serotype A isolates J. Clin. Microbiol. 37 1999 838 840
2. K.J. Kwon-Chung, J.E. Bennett, and J.C. Rhodes Taxonomic studies on Filobasidiella species and their anamorphs Antonie Van Leeuwenhoek 48 1982 25 38
3. K.J. Kwon-Chung, and J.E. Bennett Epidemiologic differences between the two varieties of Cryptococcus neoformans Am. J. Epidemiol. 120 1984 123 130
4. C.M. van der Horst, M.S. Saag, G.A. Cloud, R.J. Hamill, J.R. Graybill, J.D. Sobel, P.C. Johnson, C.U. Tuazon, T. Kerkering, B.L. Moskovitz, W.G. Powderly, and W.E. Dismukes Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group N. Engl. J. Med. 337 1997 15 21
5. J.J. Stern, B.J. Hartman, P. Sharkey, V. Rowland, K.E. Squires, H.W. Murray, and J.R. Graybill Oral fluconazole therapy for patients with acquired immunodeficiency syndrome and cryptococcosis: experience with 22 patients Am. J. Med. 85 1988 477 480
6. M.S. Saag, G.A. Cloud, J.R. Graybill, J.D. Sobel, C.U. Tuazon, P.C. Johnson, W.J. Fessel, B.L. Moskovitz, B. Wiesinger, D. Cosmatos, L. Riser, C. Thomas, R. Hafner, and W.E. Dismukes A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. National Institute of Allergy and Infectious Diseases Mycoses Study Group Clin. Infect. Dis. 28 1999 291 296
7. A.M. Sugar, and C. Saunders Oral fluconazole as suppressive therapy of disseminated cryptococcosis in patients with acquired immunodeficiency syndrome Am. J. Med. 85 1988 481 489
8. 3: demonstration of efficacy in a positive, multicenter trial Clin. Infect. Dis. 23 1996 1282 1286
9. J.R. Maenza, W.G. Merz, M.J. Romagnoli, J.C. Keruly, R.D. Moore, and J.E. Gallant Infection due to fluconazole-resistant Candida in patients with AIDS: prevalence and microbiology Clin. Infect. Dis. 24 1997 28 34
10. S.G. Revankar, W.R. Kirkpatrick, R.K. McAtee, O.P. Dib, A.W. Fothergill, S.W. Redding, M.G. Rinaldi, and T.F. Patterson Detection and significance of fluconazole resistance in oropharyngeal candidiasis in human immunodeficiency virus-infected patients J. Infect. Dis. 174 1996 821 827
11. K. Assing, H. Birgens, and M. Arendrup Cryptococcus neoformans var neoformans resistant to fluconazole in an HIV-negative patient with chronic lymphocytic leukemia Clin. Microbiol. Infect. 9 2003 441 444
12. A. Armengou, C. Porcar, J. Mascaro, and F. Garcia-Bragado Possible development of resistance to fluconazole during suppressive therapy for AIDS-associated cryptococcal meningitis Clin. Infect. Dis. 23 1996 1337 1338
13. A. Paugam, J. Dupouy-Camet, P. Blanche, J.P. Gangneux, C. Tourte-Schaefer, and D. Sicard Increased fluconazole resistance of Cryptococcus neoformans isolated from a patient with AIDS and recurrent meningitis Clin. Infect. Dis. 19 1994 975 976
14. L. Rodero, E. Mellado, A.C. Rodriguez, A. Salve, L. Guelfand, P. Cahn, M. Cuenca-Estrella, G. Davel, and J.L. Rodriguez-Tudela G484S amino acid substitution in lanosterol 14-alpha demethylase (ERG11) is related to fluconazole resistance in a recurrent Cryptococcus neoformans clinical isolate Antimicrob. Agents Chemother. 47 2003 3653 3656
15. M.A. Pfaller, J. Zhang, S.A. Messer, M.E. Brandt, R.A. Hajjeh, C.J. Jessup, M. Tumberland, E.K. Mbidde, and M.A. Ghannoum In vitro activities of voriconazole, fluconazole, itraconazole against 566 clinical isolates of Cryptococcus neoformans from the United States and Africa Antimicrob. Agents Chemother. 43 1999 169 171
16. B. Sar, D. Monchy, M. Vann, C. Keo, J.L. Sarthou, and Y. Buisson Increasing in vitro resistance to fluconazole in Cryptococcus neoformans Cambodian isolates: April 2000 to March 2002 J. Antimicrob. Chemother. 2004
17. K. Datta, N. Jain, S. Sethi, A. Rattan, A. Casadevall, and U. Banerjee Fluconazole and itraconazole susceptibility of clinical isolates of Cryptococcus neoformans at a tertiary care centre in India: a need for care J. Antimicrob. Chemother. 52 2003 683 686
18. K.L. Goa, and L.B. Barradell Fluconazole. An update of its pharmacodynamic and pharmacokinetic properties and therapeutic use in major superficial and systemic mycoses in immunocompromised patients Drugs 50 1995 658 690
19. N. Debeljak, M. Fink, and D. Rozman Many facets of mammalian lanosterol 14alpha-demethylase from the evolutionarily conserved cytochrome P450 family CYP51 Arch. Biochem. Biophys. 409 2003 159 171
20. V.F. Kalb, J.C. Loper, C.R. Dey, C.W. Woods, and T.R. Sutter Isolation of a cytochrome P-450 structural gene from Saccharomyces cerevisiae Gene 45 1986 237 245
21. D.R. Kirsch, M.H. Lai, and J. O'Sullivan Isolation of the gene for cytochrome P450L1A1 (lanosterol 14 alpha-demethylase) from Candida albicans Gene 68 1988 229 237
22. T. Joseph-Horne, and D.W. Hollomon Molecular mechanisms of azole resistance in fungi FEMS Microbiol. Lett. 149 1997 141 149
23. C.A. Hitchcock, G.W. Pye, P.F. Troke, E.M. Johnson, and D.W. Warnock Fluconazole resistance in Candida glabrata Antimicrob. Agents Chemother. 37 1993 1962 1965
24. J.L. Lopez-Ribot, R.K. McAtee, L.N. Lee, W.R. Kirkpatrick, T.C. White, D. Sanglard, and T.F. Patterson Distinct patterns of gene expression associated with development of fluconazole resistance in serial Candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis Antimicrob. Agents Chemother. 42 1998 2932 2937
25. J.H. Rex, M.G. Rinaldi, and M.A. Pfaller Resistance of Candida species to fluconazole Antimicrob. Agents Chemother. 39 1995 1 8
26. D. Sanglard, K. Kuchler, F. Ischer, J.L. Pagani, M. Monod, and J. Bille Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters Antimicrob. Agents Chemother. 39 1995 2378 2386
27. H. vanden Bossche, P. Marichal, F.C. Odds, L. Le Jeune, and M.C. Coene Characterization of an azole-resistant Candida glabrata isolate Antimicrob. Agents Chemother. 36 1992 2602 2610
28. T.C. White Increased mRNA levels of ERG16, CDR, MDR1 correlate with increases in azole resistance in Candida albicans from a patient infected with human immunodeficiency virus Antimicrob. Agents Chemother. 41 1997 1482 1487
29. K. Venkateswarlu, M. Taylor, N.J. Manning, M.G. Rinaldi, and S.L. Kelly Fluconazole tolerance in clinical isolates of Cryptococcus neoformans Antimicrob. Agents Chemother. 41 1997 748 751
30. D.C. Lamb, A. Corran, B.C. Baldwin, J. Kwon-Chung, and S.L. Kelly Resistant P45051A1 activity in azole antifungal tolerant Cryptococcus neoformans from AIDS patients FEBS Lett. 368 1995 326 330
31. B. Posteraro, M. Sanguinetti, D. Sanglard, M. La Sorda, S. Boccia, L. Romano, G. Morace, and G. Fadda Identification and characterization of a Cryptococcus neoformans ATP binding cassette (ABC) transporter-encoding gene, CnAFR1, involved in the resistance to fluconazole Mol. Microbiol. 47 2003 357 371
32. T. Yamazumi, M.A. Pfaller, S.A. Messer, A.K. Houston, L. Boyken, R.J. Hollis, I. Furuta, and R.N. Jones Characterization of heteroresistance to fluconazole among clinical isolates of Cryptococcus neoformans J. Clin. Microbiol. 41 2003 267 272
33. P. Mondon, R. Petter, G. Amalfitano, R. Luzzati, E. Concia, I. Polacheck, and K.J. Kwon-Chung Heteroresistance to fluconazole and voriconazole in Cryptococcus neoformans Antimicrob. Agents Chemother. 43 1999 1856 1861
34. K.J. Kwon-Chung, J.C. Edman, and B.L. Wickes Genetic association of mating types and virulence in Cryptococcus neoformans Infect. Immun. 60 1992 602 605
35. P. Groeneveld, N. Rolley, D.B. Kell, S.L. Kelly, and D.E. Kelly Metabolic control analysis and engineering of the yeast sterol biosynthetic pathway Mol. Biol. Rep. 29 2002 27 29
36. D.L. Clarke, G.L. Woodlee, C.M. McClelland, T.S. Seymour, and B.L. Wickes The Cryptococcus neoformans STE11α gene is similar to other fungal mitogen-activated protein kinase kinase kinase (MAPKKK) genes but is mating type specific Mol. Microbiol. 40 2001 200 213
37. B.L. Wickes, and J.C. Edman The Cryptococcus neoformans GAL7 gene and its use as an inducible promoter Mol. Microbiol. 16 1995 1099 1109
38. T.M. Rose, E.R. Schultz, J.G. Henikoff, S. Pietrokovski, C.M. McCallum, and S. Henikoff Consensus-degenerate hybrid oligonucleotide primers for amplification of distantly related sequences Nucleic Acids Res. 26 1998 1628 1635
39. S. Henikoff, J.G. Henikoff, W.J. Alford, and S. Pietrokovski Automated construction and graphical presentation of protein blocks from unaligned sequences Gene 163 1995 GC17 GC26
40. R.H. Don, P.T. Cox, B.J. Wainwright, K. Baker, and J.S. Mattick 'Touchdown' PCR to circumvent spurious priming during gene amplification Nucleic Acids Res. 19 1991 4008
41. B.L. Wickes, T.D. Moore, and K.J. Kwon-Chung Comparison of the electrophoretic karyotypes and chromosomal location of ten genes in the two varieties of Cryptococcus neoformans Microbiology 140 Pt. 3 1994 543 550
42. S.M. Keller, M.A. Viviani, M.C. Esposto, M. Cogliati, and B.L. Wickes Molecular and genetic characterization of a serotype A MATa Cryptococcus neoformans isolate Microbiology 149 2003 131 142
43. B.L. Wickes, U. Edman, and J.C. Edman The Cryptococcus neoformans STE12α gene: a putative Saccharomyces cerevisiae STE12 homologue that is mating type specific Mol. Microbiol. 26 1997 951 960
44. P.R. Williamson Biochemical and molecular characterization of the diphenol oxidase of Cryptococcus neoformans: identification as a laccase J. Bacteriol. 176 1994 656 664
45. C.M. McClelland, J. Fu, G.L. Woodlee, T.S. Seymour, and B.L. Wickes Isolation and characterization of the Cryptococcus neoformans MATa pheromone gene Genetics 160 2002 935 947
46. J. Sambrook, E.F. Fritsch, T. Maniatis, Identification of bacterial colonies that contain recombinant plasmids, in: Molecular Cloning. A Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1989, pp. 1.90-91.104
47. E. Gari, L. Piedrafita, M. Aldea, and E. Herrero A set of vectors with a tetracycline-regulatable promoter system for modulated gene expression in Saccharomyces cerevisiae Yeast 13 1997 837 848
48. N. Belgareh-Touze, M. Corral-Debrinski, H. Launhardt, J.M. Galan, T. Munder, S. Le Panse, and R. Haguenauer-Tsapis Yeast functional analysis: identification of two essential genes involved in ER to Golgi trafficking Traffic 4 2003 607 617
49. N.D. Lees, B. Skaggs, D.R. Kirsch, and M. Bard Cloning of the late genes in the ergosterol biosynthetic pathway of Saccharomyces cerevisiae†"a review Lipids 30 1995 221 226
50. H. Ito, Y. Fukuda, K. Murata, and A. Kimura Transformation of intact yeast cells treated with alkali cations J. Bacteriol. 153 1983 163 168
51. H. Kakeya, Y. Miyazaki, H. Miyazaki, K. Nyswaner, B. Grimberg, and J.E. Bennett Genetic analysis of azole resistance in the Darlington strain of Candida albicans Antimicrob. Agents Chemother. 44 2000 2985 2990
52. D. Sanglard, F. Ischer, L. Koymans, and J. Bille Amino acid substitutions in the cytochrome P-450 lanosterol 14alpha-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents Antimicrob. Agents Chemother. 42 1998 241 253
53. N. Tijet, C. Helvig, and R. Feyereisen The cytochrome P450 gene superfamily in Drosophila melanogaster: annotation, intronâ€" exon organization and phylogeny Gene 262 2001 189 198
54. J.R. Maenza, J.C. Keruly, R.D. Moore, R.E. Chaisson, W.G. Merz, and J.E. Gallant Risk factors for fluconazole-resistant candidiasis in human immunodeficiency virus-infected patients J. Infect. Dis. 173 1996 219 225
55. M.H. Lai, and D.R. Kirsch Nucleotide sequence of cytochrome P450 L1A1 (lanosterol 14 alpha-demethylase) from Candida albicans Nucleic Acids Res. 17 1989 804
56. J.A. Hargreaves, and J.P. Keon Isolation of an Ustilago maydis ERG11 gene and its expression in a mutant deficient in sterol 14 alpha-demethylase activity FEMS Microbiol. Lett. 139 1996 203 207
57. T.D. Edlind, K.W. Henry, K.A. Metera, and S.K. Katiyar Aspergillus fumigatus CYP51 sequence: potential basis for fluconazole resistance Med. Mycol. 39 2001 299 302
58. I.J. Morales, P.K. Vohra, V. Puri, T.J. Kottom, A.H. Limper, and C.F. Thomas Jr. Characterization of a lanosterol 14 alpha-demethylase from Pneumocystis carinii Am. J. Respir. Cell Mol. Biol. 29 2003 232 238